OPSOСLONUS-MYOCLONUS SYNDROME

This article provides an overview of the Russian and foreign studies on paraneoplastic opsoсlonus-myoclonus syndrome. Opsoclonus is characterized by involuntary, arrhythmic, chaotic, multi-directional saccades with horizontal, vertical and torsional components, and it is commonly accompanied by cere...

Full description

Bibliographic Details
Main Authors: N. A. Shnayder, E. A. Kantimirova, V. A. Ezhikova
Format: Article
Language:Russian
Published: ABV-press 2015-02-01
Series:Нервно-мышечные болезни
Subjects:
Online Access:https://nmb.abvpress.ru/jour/article/view/54
_version_ 1826558121655402496
author N. A. Shnayder
E. A. Kantimirova
V. A. Ezhikova
author_facet N. A. Shnayder
E. A. Kantimirova
V. A. Ezhikova
author_sort N. A. Shnayder
collection DOAJ
description This article provides an overview of the Russian and foreign studies on paraneoplastic opsoсlonus-myoclonus syndrome. Opsoclonus is characterized by involuntary, arrhythmic, chaotic, multi-directional saccades with horizontal, vertical and torsional components, and it is commonly accompanied by cerebellar ataxia and myoclonic jerks in the trunk and limbs. It is a rare neurological disorder of unknown causes which appears to be the result of an autoimmune process involving the nervous system. Paraneoplastic opsoсlonus-myoclonus syndrome is most commonly associated with small-cell lung cancer, breast cancer, ovarian cancer, non-Hodgkin's lymphoma, renal adenocarcinoma. In children, a neuroblastoma is detected in approximately 50% of cases. Many autoantibodies have been detected in patients with paraneoplastic opsoсlonusmyoclonussyndrome: this finding suggests the involvement of a humoral immune mechanism. However, most patients are seronegative for these autoantibodies. Paraneoplastic opsoсlonus-myoclonus syndrome is less responsive to immunotherapy (corticosteroids, intravenous immunoglobulin, adrenocorticotropic hormone, plasma exchange, cyclophosphamide, or rituximab) and improves only with tumor resection. Further studies are needed to further elucidate its immunopathogenesis and pathophysiology in order to develop novel and efficacious therapy.
first_indexed 2024-03-12T04:45:27Z
format Article
id doaj.art-e1dfb12eeaaa4be9a30a11386a4bbe08
institution Directory Open Access Journal
issn 2222-8721
2413-0443
language Russian
last_indexed 2025-03-14T08:39:28Z
publishDate 2015-02-01
publisher ABV-press
record_format Article
series Нервно-мышечные болезни
spelling doaj.art-e1dfb12eeaaa4be9a30a11386a4bbe082025-03-02T12:54:41ZrusABV-pressНервно-мышечные болезни2222-87212413-04432015-02-0103222610.17650/2222-8721-2013-0-3-22-2648OPSOСLONUS-MYOCLONUS SYNDROMEN. A. Shnayder0E. A. Kantimirova1V. A. Ezhikova2Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of the Russian Federation Clinical Hospital Fifty-One, Federal Biomedical Agency, ZheleznogorskProf. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of the Russian FederationProf. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of the Russian Federation A.I. Kryzhanovsky Krasnoyarsk Territorial Cancer CenterThis article provides an overview of the Russian and foreign studies on paraneoplastic opsoсlonus-myoclonus syndrome. Opsoclonus is characterized by involuntary, arrhythmic, chaotic, multi-directional saccades with horizontal, vertical and torsional components, and it is commonly accompanied by cerebellar ataxia and myoclonic jerks in the trunk and limbs. It is a rare neurological disorder of unknown causes which appears to be the result of an autoimmune process involving the nervous system. Paraneoplastic opsoсlonus-myoclonus syndrome is most commonly associated with small-cell lung cancer, breast cancer, ovarian cancer, non-Hodgkin's lymphoma, renal adenocarcinoma. In children, a neuroblastoma is detected in approximately 50% of cases. Many autoantibodies have been detected in patients with paraneoplastic opsoсlonusmyoclonussyndrome: this finding suggests the involvement of a humoral immune mechanism. However, most patients are seronegative for these autoantibodies. Paraneoplastic opsoсlonus-myoclonus syndrome is less responsive to immunotherapy (corticosteroids, intravenous immunoglobulin, adrenocorticotropic hormone, plasma exchange, cyclophosphamide, or rituximab) and improves only with tumor resection. Further studies are needed to further elucidate its immunopathogenesis and pathophysiology in order to develop novel and efficacious therapy.https://nmb.abvpress.ru/jour/article/view/54paraneoplastic neurological syndromeopsoсlonus-myoclonus syndromecancerpathogenesisclinicsdiagnosistreatment
spellingShingle N. A. Shnayder
E. A. Kantimirova
V. A. Ezhikova
OPSOСLONUS-MYOCLONUS SYNDROME
Нервно-мышечные болезни
paraneoplastic neurological syndrome
opsoсlonus-myoclonus syndrome
cancer
pathogenesis
clinics
diagnosis
treatment
title OPSOСLONUS-MYOCLONUS SYNDROME
title_full OPSOСLONUS-MYOCLONUS SYNDROME
title_fullStr OPSOСLONUS-MYOCLONUS SYNDROME
title_full_unstemmed OPSOСLONUS-MYOCLONUS SYNDROME
title_short OPSOСLONUS-MYOCLONUS SYNDROME
title_sort opsoсlonus myoclonus syndrome
topic paraneoplastic neurological syndrome
opsoсlonus-myoclonus syndrome
cancer
pathogenesis
clinics
diagnosis
treatment
url https://nmb.abvpress.ru/jour/article/view/54
work_keys_str_mv AT nashnayder opsoslonusmyoclonussyndrome
AT eakantimirova opsoslonusmyoclonussyndrome
AT vaezhikova opsoslonusmyoclonussyndrome